Human mast cells costimulate T cells through a CD28-independent interaction.

about

Human mast cells costimulate T cells through a CD28-independent interaction.

Item

http://www.wikidata.org/entity/Q40010797

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Human mast cells costimulate T cells through a CD28-independent interaction.

@en

type

Item

label

Human mast cells costimulate T cells through a CD28-independent interaction.

@en

prefLabel

Human mast cells costimulate T cells through a CD28-independent interaction.

@en

P1476

Human mast cells costimulate T cells through a CD28-independent interaction.

@en

P2093

Annemarie L Dorjée

http://www.w3.org/2001/XMLSchema#string

Jolien Suurmond

http://www.w3.org/2001/XMLSchema#string

Tom W J Huizinga

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular mechanisms of T cell co-stimulation and co-inhibition

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells

Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data.

Cell-cell cooperation at the T helper cell/mast cell immunological synapse.

Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells

Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.

P304

1132-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.201545914

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rene E Toes

P577

2016-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26860071

http://www.w3.org/2001/XMLSchema#string